Abstract |
Most lysosomal storage diseases, including mucopolysaccharidosis, affect the central nervous system (CNS). They often induce severe and progressive mental retardation. Replacement therapy by purified enzyme infusions is a promising approach for the treatment of peripheral organs but without effect on CNS pathology because the enzyme cannot cross the blood-brain barrier. Intracranial injection of recombinant adeno-associated virus (AAV) vectors offers an alternative for sustained local enzyme delivery from genetically engineered cells. We stereotactically injected an AAV vector containing the human beta-glucuronidase cDNA into the striatum of adult mice severely affected by mucopolysaccharidosis type VII at the time of treatment. Six weeks later, beta-glucuronidase activity in the injected hemisphere was comparable to that of heterozygous mice, which have a normal phenotype. Areas staining positive for enzyme activity enlarged with time, representing more than 10% of the hemisphere volume by 16 weeks. A complete reversion of lysosomal storage lesions was evident in these areas, as well as in most neurons located in surrounding negative areas and in the noninjected hemisphere. Thus, a single intracerebral injection of AAV vectors could achieve a broad and sustained lysosomal enzyme delivery, allowing for stable reversion of storage lesions in a significant fraction of the adult brain.
|
Authors | A Bosch, E Perret, N Desmaris, J M Heard |
Journal | Molecular therapy : the journal of the American Society of Gene Therapy
(Mol Ther)
Vol. 1
Issue 1
Pg. 63-70
(Jan 2000)
ISSN: 1525-0016 [Print] United States |
PMID | 10933913
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA, Complementary
- RNA, Messenger
- Glucuronidase
|
Topics |
- Animals
- Brain
(enzymology, pathology)
- DNA, Complementary
(administration & dosage, genetics)
- Dependovirus
(genetics)
- Gene Expression
- Genetic Therapy
(methods)
- Genetic Vectors
- Glucuronidase
(genetics, metabolism)
- Histocytochemistry
- Humans
- In Situ Hybridization
- Injections
- Mice
- Mice, Mutant Strains
- Mucopolysaccharidosis VII
(enzymology, pathology, therapy)
- RNA, Messenger
(genetics, metabolism)
|